Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
BMJ
.
2021 Feb 1:372:n296.
doi: 10.1136/bmj.n296.
Author
Elisabeth Mahase
1
Affiliation
1
The BMJ.
PMID:
33526412
DOI:
10.1136/bmj.n296
No abstract available